Bixiye
QP32-22 Commercial Pharmacy Benefit Exclusion for EnjaymoTM
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2022
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1111 - 1120 ee natiijooyinka 3604
Bixiye
QP33-22 MHCP Pharmacy Benefit Exclusion for CarvyktiTM and EnjaymoTM
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2022
Bixiye
QP34-22 Minnesota Senior Health Options (MSHO) Model of Care: Annual Training Requirement Reminder
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2022
Bixiye
QP35-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective June 14, 2022
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2022
Bixiye
OTC COVID-19 At-Home Test - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2025
Bixiye
Biologic Immunomodulators (For Pharmacy Benefits Only) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2025
Bixiye
QP24-22 Join the TruHearing Audiology and Hearing Aid Network
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP25-22 Reminder for New to Market Medical Drugs: Medical Drug Evaluation Process List
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP26-22 Provider Directory Validation (PDV) Tool
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP27-22 MHCP Pharmacy Benefit Exclusion for Fyarro
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022